Cargando…
Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708150/ https://www.ncbi.nlm.nih.gov/pubmed/26812943 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.06.02 |
| _version_ | 1782409409953005568 |
|---|---|
| author | Eskens, Ferry ALM Haberkorn, Brigitte |
| author_facet | Eskens, Ferry ALM Haberkorn, Brigitte |
| author_sort | Eskens, Ferry ALM |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4708150 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47081502016-01-26 Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor Eskens, Ferry ALM Haberkorn, Brigitte Transl Androl Urol Editorial AME Publishing Company 2012-12 /pmc/articles/PMC4708150/ /pubmed/26812943 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.06.02 Text en 2012 Translational Andrology and Urology. All rights reserved. |
| spellingShingle | Editorial Eskens, Ferry ALM Haberkorn, Brigitte Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor |
| title | Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor |
| title_full | Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor |
| title_fullStr | Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor |
| title_full_unstemmed | Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor |
| title_short | Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor |
| title_sort | towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective vegfr tyrosine kinase inhibitor |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708150/ https://www.ncbi.nlm.nih.gov/pubmed/26812943 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.06.02 |
| work_keys_str_mv | AT eskensferryalm towardsnewtreatmentoptionsforrenalcellcarcinomadevelopmentandclinicalresultsoftivozanibaselectivevegfrtyrosinekinaseinhibitor AT haberkornbrigitte towardsnewtreatmentoptionsforrenalcellcarcinomadevelopmentandclinicalresultsoftivozanibaselectivevegfrtyrosinekinaseinhibitor |